title: Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.
authors.affiliation: Service de Microbiologie, Centre Hospitalier de Versailles, Le Chesnay, France.
authors.forename: Martine
authors.initials: M
authors.lastname: Harzic
authors.forename: Isabelle
authors.initials: I
authors.lastname: Pellegrin
authors.forename: Christiane
authors.initials: C
authors.lastname: Deveau
authors.forename: Marie-Laure
authors.initials: ML
authors.lastname: Chaix
authors.forename: Béatrice
authors.initials: B
authors.lastname: Dubeaux
authors.forename: Isabelle
authors.initials: I
authors.lastname: Garrigue
authors.forename: Nicole
authors.initials: N
authors.lastname: Ngo
authors.forename: Christine
authors.initials: C
authors.lastname: Rouzioux
authors.forename: Cécile
authors.initials: C
authors.lastname: Goujard
authors.forename: Bruno
authors.initials: B
authors.lastname: Hoen
authors.forename: Daniel
authors.initials: D
authors.lastname: Sereni
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Delfraissy
authors.forename: Laurence
authors.initials: L
authors.lastname: Meyer
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D015331:Cohort Studies; D024882:Drug Resistance, Viral / Q000235:genetics*; D005260:Female; D005602:France; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D016333:HIV Protease / Q000235:genetics*; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D012367:RNA, Viral; D019438:Ritonavir / Q000627:therapeutic use; D019562:Viral Load; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D012367:RNA, Viral; D019259:Lamivudine; D015215:Zidovudine; D054303:HIV Reverse Transcriptase; D016333:HIV Protease; D019438:Ritonavir